Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Understanding the FDA Process Is Critical for Young Companies.

PMID: 42558082 ·

Jesse Courtier, Rick Beberman

JournalJournal of medical extended reality
Year
PMID42558082

Abstract

Our team recently led our augmented reality preoperative planning software application through Food and Drug Administration 510(k) clearance as a class 2 medical device. As augmented and virtual reality play an increasing role in health care, more early-stage companies will be required to seek this clearance. Often founders at these companies lack regulatory experience, which can make the process difficult and inefficient. Our experience was the first time for us. For those in a similar position

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.